About Daniel Lim

Daniel Lim is a partner in Kirkland’s IP litigation practice in London focusing on high-stakes life science patent litigation, particularly in the pharmaceutical industry, diagnostics, precision medicine and cell and gene therapy. He is also experienced in representing clients involved in complex SEP and FRAND licensing disputes. In addition to UK litigation, Daniel is regularly called upon to assist clients in devising, co-ordinating and executing patent strategies for complex multijurisdictional disputes at a pan-European and global scale. He is active as a member of AIPPI and EPLAW, including as vice-chair of AIPPI’s standing committee on biotechnology.